Serious infections caused by methicillin-resistant Staphylococcus aureus

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Medicine

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) emerged over 4 decades ago and is now a global threat in healthcare and community settings.
• Increasing vancomycin resistance in MRSA complicates treatment, necessitating careful consideration of newer agents like daptomycin and linezolid.

Purpose of the Study:

• To describe clinical features and management of difficult-to-treat MRSA infections, specifically bacteremia/endocarditis and osteomyelitis.
• To review community-associated MRSA (CA-MRSA) infections.
• To discuss preventive strategies against MRSA.

Main Methods:

• Literature review of clinical features and management of MRSA infections.
• Review of emerging MRSA resistance patterns.
• Summary of current and novel therapeutic options.
• Overview of community-acquired MRSA and prevention.

Main Results:

• MRSA infections, including bacteremia, endocarditis, and osteomyelitis, present significant clinical challenges.
• Emerging vancomycin resistance necessitates alternative treatment strategies.
• Newer antibiotics offer expanded therapeutic choices but require complex decision-making.

Conclusions:

• Effective management of challenging MRSA infections requires a thorough understanding of clinical presentations and evolving resistance.
• Careful selection of antibiotics, including newer agents, is crucial for successful treatment outcomes.
• Prevention strategies are essential to curb the spread of MRSA in both hospital and community environments.